COMPOSITIONS IMMUNOGÈNES À BASE DU VIRUS DE L'HÉPATITE C COMPRENANT EN TANT QU'ADJUVANT UN DINUCLÉOTIDE CYCLIQUE OU UNE ARCHAEOSOME ET LEURS PROCÉDÉS D'UTILISATION
The present disclosure provides immunogenic compositions comprising: a) hepatitis C virus (HCV) E1E2 heterodimers, HCV E2, or HCV E1; and b) an adjuvant, where the adjuvant is a cyclic dinucleotide or an archaeosome. The present disclosure provides methods of inducing an immune response in an individual to HCV, the methods comprising administering to an individual an effective amount of an immunogenic composition of the present disclosure.